Anti-PPP2R3C antibody (1-160 aa) (STJ11105956)

SKU:
STJ11105956

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:2000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Gene Symbol: PPP2R3C
Gene ID: 55012
Uniprot ID: P2R3C_HUMAN
Immunogen Region: 1-160 aa
Specificity: Recombinant fusion protein containing a sequence corresponding to amino acids 1-160 of human PPP2R3C (NP_060387.2).
Immunogen Sequence: MDWKEVLRRRLATPNTCPNK KKSEQELKDEEMDLFTKYYS EWKGGRKNTNEFYKTIPRFY YRLPAEDEVLLQKLREESRA VFLQRKSRELLDNEELQNLW FLLDKHQTPPMIGEEAMINY ENFLKVGEKAGAKCKQFFTA KVFAKLLHTDSYGRISIMQF
Tissue Specificity Ubiquitously expressed in brain and other tissues.
Function May regulate MCM3AP phosphorylation through phosphatase recruitment. May act as a negative regulator of ABCB1 expression and function through the dephosphorylation of ABCB1 by TFPI2/PPP2R3C complex. May play a role in the activation-induced cell death of B-cells.
Protein Name Serine/Threonine-Protein Phosphatase 2a Regulatory Subunit B'' Subunit Gamma
Protein Phosphatase Subunit G5pr
Rhabdomyosarcoma Antigen Mu-Rms-40.6a/6c
Cellular Localisation Nucleus
Cytoplasm
Excluded From The Nucleoli
Localization Is Cell Cycle-Dependent
Localizes To The Cytoplasm During Cytokinesis
Alternative Antibody Names Anti-Serine/Threonine-Protein Phosphatase 2a Regulatory Subunit B'' Subunit Gamma antibody
Anti-Protein Phosphatase Subunit G5pr antibody
Anti-Rhabdomyosarcoma Antigen Mu-Rms-40.6a/6c antibody
Anti-PPP2R3C antibody
Anti-C14orf10 antibody
Anti-G5PR antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance